Phase I / II Gene Therapy Trial of Fanconi anemia patients with a new orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action - EUROFANCOLEN

Project Details


summary not available
Effective start/end date1/01/1331/12/18


  • European Commission: €5,380,165.00

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.